Task: Answer the multiple choice question.
Query: Which drug exhibits a -46.834% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1ccc(O)c(C=Nc2cc(C)ccc2O)c1
b) Cc1ccccc1N1CCN(C2CCCN(C(=O)c3ccc(Cl)s3)C2)CC1
Answer: b. Cc1ccccc1N1CCN(C2CCCN(C(=O)c3ccc(Cl)s3)C2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1N1CCN(C2CCCN(C(=O)c3ccc(Cl)s3)C2)CC1
Cc1ccccc1N1CCN(C2CCCN(C(=O)c3ccc(Cl)s3)C2)CC1
(5-chlorothiophen-2-yl)-[3-[4-(2-methylphenyl)piperazin-1-yl]piperidin-1-yl]methanone